{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:39:59Z","timestamp":1777444799571,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS071127 and R21NS064316"],"award-info":[{"award-number":["R01NS071127 and R21NS064316"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12975-017-0563-1","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T09:11:29Z","timestamp":1503479489000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-583X","authenticated-orcid":false,"given":"Bing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikunj","family":"Satani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duyen M.","family":"Nghiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoPei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Aronowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean I.","family":"Savitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"563_CR1","doi-asserted-by":"publisher","unstructured":"Kastrup A, Groschel K, Ringer TM, Redecker C, Cordesmeyer R, Witte OW, et al. Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke. 2008;39(8):2385\u20137. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.107.505420\n                    \n                  .","DOI":"10.1161\/STROKEAHA.107.505420"},{"issue":"8","key":"563_CR2","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/01.STR.0000023534.37670.F7","volume":"33","author":"RM Dijkhuizen","year":"2002","unstructured":"Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke. 2002;33(8):2100\u20134.","journal-title":"Stroke"},{"issue":"5","key":"563_CR3","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/01.STR.0000014619.59851.65","volume":"33","author":"C Neumann-Haefelin","year":"2002","unstructured":"Neumann-Haefelin C, Brinker G, Uhlenkuken U, Pillekamp F, Hossmann KA, Hoehn M. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain. Stroke. 2002;33(5):1392\u20138.","journal-title":"Stroke"},{"key":"563_CR4","doi-asserted-by":"publisher","unstructured":"Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med. 2014;2(8):81. \n                    https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.08\n                    \n                  .","DOI":"10.3978\/j.issn.2305-5839.2014.08.08"},{"key":"563_CR5","doi-asserted-by":"publisher","unstructured":"Rodriguez-Frutos B, Otero-Ortega L, Gutierrez-Fernandez M, Fuentes B, Ramos-Cejudo J, Diez-Tejedor E. Stem cell therapy and administration routes after stroke. Transl Stroke Res. 2016;7(5):378\u201387. \n                    https:\/\/doi.org\/10.1007\/s12975-016-0482-6\n                    \n                  .","DOI":"10.1007\/s12975-016-0482-6"},{"key":"563_CR6","doi-asserted-by":"publisher","unstructured":"Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res. 2004;1007(1\u20132):1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2003.09.084\n                    \n                  .","DOI":"10.1016\/j.brainres.2003.09.084"},{"key":"563_CR7","doi-asserted-by":"publisher","unstructured":"Giraldi-Guimardes A, Rezende-Lima M, Bruno FP, Mendez-Otero R. Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res. 2009;1266:108\u201320. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2009.01.062\n                    \n                  .","DOI":"10.1016\/j.brainres.2009.01.062"},{"key":"563_CR8","doi-asserted-by":"publisher","unstructured":"Yang B, Strong R, Sharma S, Brenneman M, Mallikarjunarao K, Xi X, et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res. 2011;89(6):833\u20139. \n                    https:\/\/doi.org\/10.1002\/jnr.22614\n                    \n                  .","DOI":"10.1002\/jnr.22614"},{"key":"563_CR9","doi-asserted-by":"publisher","unstructured":"Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D, et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017;16(5):360\u20138. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30046-7\n                    \n                  .","DOI":"10.1016\/S1474-4422(17)30046-7"},{"key":"563_CR10","doi-asserted-by":"publisher","unstructured":"Moniche F, Rosado-de-Castro PH, Escudero I, Zapata E, de la Torre Laviana FJ, Mendez-Otero R, et al. Increasing dose of autologous bone marrow mononuclear cells transplantation is related to stroke outcome: results from a pooled analysis of two clinical trials. Stem Cells Int. 2016;2016:8657173. \n                    https:\/\/doi.org\/10.1155\/2016\/8657173\n                    \n                  .","DOI":"10.1155\/2016\/8657173"},{"key":"563_CR11","doi-asserted-by":"publisher","unstructured":"Moniche F, Escudero I, Zapata-Arriaza E, Usero-Ruiz M, Prieto-Leon M, de la Torre J, et al. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial. Int J Stroke. 2015;10(7):1149\u201352. \n                    https:\/\/doi.org\/10.1111\/ijs.12520\n                    \n                  .","DOI":"10.1111\/ijs.12520"},{"key":"563_CR12","doi-asserted-by":"publisher","unstructured":"Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, et al. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke. 2014;45(12):3618\u201324. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.007028\n                    \n                  .","DOI":"10.1161\/STROKEAHA.114.007028"},{"key":"563_CR13","doi-asserted-by":"publisher","unstructured":"Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011;70(1):59\u201369. \n                    https:\/\/doi.org\/10.1002\/ana.22458\n                    \n                  .","DOI":"10.1002\/ana.22458"},{"key":"563_CR14","doi-asserted-by":"publisher","unstructured":"Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J, et al. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke. 2013;44(12):3463\u201372. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.000821\n                    \n                  .","DOI":"10.1161\/STROKEAHA.111.000821"},{"key":"563_CR15","doi-asserted-by":"publisher","unstructured":"Suda S, Yang B, Schaar K, Xi X, Pido J, Parsha K, et al. Autologous bone marrow mononuclear cells exert broad effects on short- and long-term biological and functional outcomes in rodents with Intracerebral hemorrhage. Stem Cells Dev. 2015;24(23):2756\u201366. \n                    https:\/\/doi.org\/10.1089\/scd.2015.0107\n                    \n                  .","DOI":"10.1089\/scd.2015.0107"},{"key":"563_CR16","doi-asserted-by":"publisher","unstructured":"Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323\u20138. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.110.608257\n                    \n                  .","DOI":"10.1161\/STROKEAHA.110.608257"},{"key":"563_CR17","doi-asserted-by":"publisher","unstructured":"Gurney KJ, Estrada EY, Rosenberg GA. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis. 2006;23(1):87\u201396. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.02.006\n                    \n                  .","DOI":"10.1016\/j.nbd.2006.02.006"},{"key":"563_CR18","doi-asserted-by":"publisher","unstructured":"Bedi SS, Walker PA, Shah SK, Jimenez F, Thomas CP, Smith P, et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial\/macrophage response and improves spatial learning after traumatic brain injury. J Trauma Acute Care Surg. 2013;75(3):410\u20136. \n                    https:\/\/doi.org\/10.1097\/TA.0b013e31829617c6\n                    \n                  .","DOI":"10.1097\/TA.0b013e31829617c6"},{"key":"563_CR19","doi-asserted-by":"publisher","unstructured":"Shi Y, Leak RK, Keep RF, Chen J. Translational stroke research on blood-brain barrier damage: challenges, perspectives, and goals. Transl Stroke Res. 2016;7(2):89\u201392. \n                    https:\/\/doi.org\/10.1007\/s12975-016-0447-9\n                    \n                  .","DOI":"10.1007\/s12975-016-0447-9"},{"key":"563_CR20","doi-asserted-by":"publisher","unstructured":"Fan X, Qiu J, Yu Z, Dai H, Singhal AB, Lo EH, et al. A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke. 2012;43(2):567\u201370. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.635250\n                    \n                  .","DOI":"10.1161\/STROKEAHA.111.635250"},{"issue":"2","key":"563_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653411","volume":"46","author":"C Korninger","year":"1981","unstructured":"Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost. 1981;46(2):561\u20135.","journal-title":"Thromb Haemost"},{"issue":"11","key":"563_CR22","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","volume":"30","author":"M Fiorelli","year":"1999","unstructured":"Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European cooperative acute stroke study I (ECASS I) cohort. Stroke. 1999;30(11):2280\u20134.","journal-title":"Stroke"},{"key":"563_CR23","doi-asserted-by":"publisher","unstructured":"Fagan SC, Lapchak PA, Liebeskind DS, Ishrat T, Ergul A. Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res. 2013;4(3):322\u20137. \n                    https:\/\/doi.org\/10.1007\/s12975-012-0222-5\n                    \n                  .","DOI":"10.1007\/s12975-012-0222-5"},{"issue":"3","key":"563_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","volume":"17","author":"JB Bederson","year":"1986","unstructured":"Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472\u20136.","journal-title":"Stroke"},{"key":"563_CR25","doi-asserted-by":"publisher","unstructured":"Zhuang Z, Yang B, Theus MH, Sick JT, Bethea JR, Sick TJ, et al. EphrinBs regulate D-serine synthesis and release in astrocytes. J Neurosci. 2010;30(47):16015\u201324. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0481-10.2010\n                    \n                  .","DOI":"10.1523\/JNEUROSCI.0481-10.2010"},{"key":"563_CR26","doi-asserted-by":"publisher","unstructured":"Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta JC, et al. Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res. 2010;88(13):2869\u201376. \n                    https:\/\/doi.org\/10.1002\/jnr.22452\n                    \n                  .","DOI":"10.1002\/jnr.22452"},{"issue":"11","key":"563_CR27","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1161\/01.STR.28.11.2296","volume":"28","author":"TF Choudhri","year":"1997","unstructured":"Choudhri TF, Hoh BL, Solomon RA, Connolly ES Jr, Pinsky DJ. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke. 1997;28(11):2296\u2013302.","journal-title":"Stroke"},{"key":"563_CR28","doi-asserted-by":"publisher","unstructured":"Leigh R, Jen SS, Hillis AE, Krakauer JW, Barker PB. Stir et al. pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator. Stroke. 2014;45(7):2030\u20135. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.114.005249\n                    \n                  .","DOI":"10.1161\/STROKEAHA.114.005249"},{"key":"563_CR29","doi-asserted-by":"publisher","unstructured":"Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79(13 Suppl 1):S52\u20137. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182697e70\n                    \n                  .","DOI":"10.1212\/WNL.0b013e3182697e70"},{"key":"563_CR30","doi-asserted-by":"publisher","unstructured":"Suzuki Y, Nagai N, Umemura K, Collen D, Lijnen HR. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J Thromb Haemost. 2007;5(8):1732\u20139. \n                    https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02628.x\n                    \n                  .","DOI":"10.1111\/j.1538-7836.2007.02628.x"},{"key":"563_CR31","doi-asserted-by":"publisher","unstructured":"Neuhaus W, Gaiser F, Mahringer A, Franz J, Riethmuller C, Forster C. The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front Cell Neurosci. 2014;8:352. \n                    https:\/\/doi.org\/10.3389\/fncel.2014.00352\n                    \n                  .","DOI":"10.3389\/fncel.2014.00352"},{"key":"563_CR32","doi-asserted-by":"publisher","unstructured":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N Engl J Med 1995;333(24):1581\u20137. doi:\n                    https:\/\/doi.org\/10.1056\/NEJM199512143332401\n                    \n                  .","DOI":"10.1056\/NEJM199512143332401"},{"issue":"13","key":"563_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA. 1995;274(13):1017\u201325.","journal-title":"JAMA"},{"key":"563_CR34","doi-asserted-by":"crossref","unstructured":"Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA stroke study group. Stroke 1997;28(11):2109\u201318.","DOI":"10.1161\/01.STR.28.11.2109"},{"key":"563_CR35","doi-asserted-by":"publisher","unstructured":"Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2000;20(3):452\u20137. \n                    https:\/\/doi.org\/10.1097\/00004647-200003000-00002\n                    \n                  .","DOI":"10.1097\/00004647-200003000-00002"},{"issue":"9","key":"563_CR36","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/00001756-199906230-00027","volume":"10","author":"G Brinker","year":"1999","unstructured":"Brinker G, Pillekamp F, Hossmann KA. Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats. Neuroreport. 1999;10(9):1943\u20136.","journal-title":"Neuroreport"},{"key":"563_CR37","doi-asserted-by":"publisher","unstructured":"Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab. 2001;21(8):964\u201371. \n                    https:\/\/doi.org\/10.1097\/00004647-200108000-00009\n                    \n                  .","DOI":"10.1097\/00004647-200108000-00009"},{"key":"563_CR38","doi-asserted-by":"publisher","unstructured":"Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185\u201399. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2013.203\n                    \n                  .","DOI":"10.1038\/jcbfm.2013.203"},{"key":"563_CR39","doi-asserted-by":"publisher","unstructured":"Yang B, Hamilton JA, Valenzuela KS, Bogaerts A, Xi X, Aronowski J, et al. Multipotent adult progenitor cells enhance recovery after stroke by modulating the immune response from the spleen. Stem Cells. 2017;35(5):1290\u2013302. \n                    https:\/\/doi.org\/10.1002\/stem.2600\n                    \n                  .","DOI":"10.1002\/stem.2600"},{"key":"563_CR40","doi-asserted-by":"publisher","unstructured":"Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol. 2010;225(2):341\u201352. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2010.07.005\n                    \n                  .","DOI":"10.1016\/j.expneurol.2010.07.005"},{"key":"563_CR41","doi-asserted-by":"publisher","unstructured":"Sashindranath M, Sales E, Daglas M, Freeman R, Samson AL, Cops EJ, et al. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Brain. 2012;135(Pt 11):3251\u201364. \n                    https:\/\/doi.org\/10.1093\/brain\/aws178\n                    \n                  .","DOI":"10.1093\/brain\/aws178"},{"key":"563_CR42","doi-asserted-by":"publisher","unstructured":"Yang B, Parsha K, Schaar K, Satani N, Xi X, Aronowski J, et al. Cryopreservation of bone marrow mononuclear cells alters their viability and subpopulation composition but not their treatment effects in a rodent stroke model. Stem Cells Int. 2016;2016:5876836. \n                    https:\/\/doi.org\/10.1155\/2016\/5876836\n                    \n                  .","DOI":"10.1155\/2016\/5876836"},{"key":"563_CR43","doi-asserted-by":"publisher","unstructured":"Glover LE, Tajiri N, Weinbren NL, Ishikawa H, Shinozuka K, Kaneko Y, et al. A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived stem cells. Transl Stroke Res. 2012;3(1):90\u20138. \n                    https:\/\/doi.org\/10.1007\/s12975-011-0127-8\n                    \n                  .","DOI":"10.1007\/s12975-011-0127-8"},{"key":"563_CR44","doi-asserted-by":"publisher","unstructured":"Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J. Hydrogen sulfide attenuates tissue plasminogen activator-induced cerebral hemorrhage following experimental stroke. Transl Stroke Res. 2016;7(3):209\u201319. \n                    https:\/\/doi.org\/10.1007\/s12975-016-0459-5\n                    \n                  .","DOI":"10.1007\/s12975-016-0459-5"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12975-017-0563-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-017-0563-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:47:43Z","timestamp":1589737663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12975-017-0563-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["563"],"URL":"https:\/\/doi.org\/10.1007\/s12975-017-0563-1","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]},"assertion":[{"value":"6 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by R01NS071127 and R21NS064316.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments and surgical procedures were approved by the University of Texas Health Science Center Animal Welfare Committee and followed NIH guidelines and regulations.This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}